Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Myasthenia Gravis Transplant: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Myasthenia Gravis Transplant: 1 US clinical trial tracked, none currently recruiting.

Myasthenia Gravis Transplant is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Fred Hutchinson Cancer Center, running 1 of these trials.

Enrollment posture brief

Registry condition myasthenia-gravis-transplant

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Myasthenia Gravis Transp (th…0%
Open-enrollment share among volume-matched conditions near Myasthenia Gravis Transplant

Myasthenia Gravis Transplant has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Myasthenia Gravis Transplant on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Myasthenia Gravis Transplant is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Myasthenia Gravis Transplant records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Autologous Hematopoietic Stem Cell Transplantation Procedure
1 trials
Carmustine Drug
1 trials
Cytarabine Drug
1 trials
Anti-Thymocyte Globulin Biological
1 trials
Etoposide Drug
1 trials

US sites by state

Facility locations filed on Myasthenia Gravis Transplant trials. A trial with sites in several states counts in each.

Washington 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Myasthenia Gravis Transplant page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Myasthenia Gravis Transplant trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Fred Hutchinson Cancer Center sponsors the most Myasthenia Gravis Transplant trials on record, review their full trial history before evaluating a specific study. See Fred Hutchinson Cancer Center's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Myasthenia Gravis Transplant condition card totals 1 registered trials; most-linked intervention Autologous Hematopoietic Stem Cell Transplantation; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.